| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | 1 | — |
| Sell | — | — | — | — | — | — | — | — | — | — | — | — |
| total | individual payouts | |
|---|---|---|
| 2026 | 2.33 |
—
—
—
|
| 2025 | 2.82 |
—
—
—
—
|
| 2024 | 2.56 |
—
—
—
—
|
| 2023 | 2.44 |
—
—
—
—
|
| 2022 | 2.44 |
—
—
—
—
|
| 2021 | 2.44 |
—
—
—
—
|
| 2020 | 2.70 |
—
—
—
—
|
| 2019 | 3.48 |
—
—
—
—
|
| 2018 | 3.48 |
—
—
—
—
|
| 2017 | 3.48 |
—
—
—
—
|
| 2016 | 3.44 |
—
—
—
—
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 2,076.08 | 3,711.46 | 5,209.54 | 2,097.16 |
| Receivables | 1,523.64 | 1,712.40 | 2,373.41 | 2,810.63 |
| Inventory | — | — | — | — |
| Other | — | — | — | — |
| 4,961.31 | 7,228.90 | 9,414.16 | 7,860.50 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | — | — | — | — |
| ST’ Debt | — | — | — | — |
| Other | — | — | — | — |
| 1,521.66 | 1,713.37 | 2,719.81 | 2,490.80 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 3,351.93 | 3,544.59 | — | — |
—
|
| ’25 | 2,423.09 | 2,548.24 | 2,685.69 | 3,181.01 |
10,838.03
|
| ’24 | 1,859.74 | 1,824.88 | 2,055.66 | 2,250.83 |
7,991.12
|
| ’23 | 1,560.73 | 1,665.48 | 1,662.01 | 1,749.78 |
6,638.00
|
| ’22 | 1,395.70 | 1,472.54 | 1,473.84 | 1,518.53 |
5,860.62
|
| ’21 | 1,052.06 | 1,140.99 | 1,239.80 | 1,309.26 |
4,742.12
|
| ’20 | 1,258.60 | 1,188.48 | 1,036.87 | 1,122.02 |
4,605.97
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 670.01 | 1,003.63 | — | — |
—
|
| ’25 | 598.96 | 770.03 | 858.36 | 654.33 |
2,881.68
|
| ’24 | 406.81 | 605.42 | 684.98 | 559.21 |
2,256.42
|
| ’23 | 376.06 | 416.25 | 439.06 | 370.50 |
1,601.86
|
| ’22 | 324.52 | 394.81 | 355.99 | 253.39 |
1,328.71
|
| ’21 | 303.66 | 335.26 | 353.08 | 283.33 |
1,275.33
|
| ’20 | 411.86 | 399.76 | 297.97 | 255.17 |
1,364.76
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 2,013.28 | 1,258.07 | — | — |
—
|
| ’25 | 550.08 | 517.93 | 611.15 | 5,372.79 |
7,051.95
|
| ’24 | 87.37 | 297.91 | 286.45 | 235.78 |
907.50
|
| ’23 | 80.15 | 35.01 | 135.38 | (84.56) |
165.99
|
| ’22 | (431.69) | (703.34) | (737.52) | 2,293.00 |
420.45
|
| ’21 | 272.37 | (86.89) | (1,416.00) | (1,208.56) |
(2,439.08)
|
| ’20 | 704.29 | 1,499.48 | 2,118.74 | (7.81) |
4,314.70
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 1.02 | 0.61 | — | — |
—
|
| ’25 | 0.40 | 0.45 | 0.41 | 0.14 |
1.39
|
| ’24 | 0.22 | 0.42 | 0.73 | 0.19 |
1.57
|
| ’23 | 0.05 | 0.20 | 0.24 | 0.15 |
0.66
|
| ’22 | 0.14 | 0.20 | (0.01) | (0.01) |
0.30
|
| ’21 | 0.17 | 0.06 | 0.42 | 0.13 |
0.78
|
| ’20 | 0.75 | 0.42 | 0.77 | 0.39 |
2.33
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 56.50 | 65.18 | 85.40 | 123.11 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | 99.43 | 93.42 | 140.75 | 209.05 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 514 | 533 | 685 | 712 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 11.40 | 12.45 | 11.67 | 15.22 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5,860.62 | 6,638.00 | 7,991.12 | 10,838.03 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 39.10% | 40.38% | 39.43% | 40.22% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 173.06 | 350.05 | 524.44 | (480.02) | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.95% | 5.27% | 6.56% | (4.43%) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 160.57 | 358.14 | 972.86 | 961.84 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,336.91 | 1,443.22 | 1,679.63 | 2,138.53 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 12.68 | 12.87 | 13.25 | 16.28 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 0.31 | 0.66 | 1.58 | 1.41 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.87 | 3.11 | 3.74 | 4.33 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1.97) | (2.78) | (2.24) | 6.27 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.91 | 0.32 | 1.51 | 10.59 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 45.46 | 50.58 | 53.59 | 64.51 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 462.19 | 515.63 | 602.98 | 665.64 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 209.22 | 138.83 | 80.27 | 130.71 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5.28 | 7.01 | 9.51 | 11.40 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | 1.47 | 1.78 | 2.35 | 2.88 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7.76 | 9.10 | 11.01 | 12.71 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 108.19 | 363.95 | 96.97 | 19.53 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,328.71 | 1,601.86 | 2,256.42 | 2,881.68 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (908.26) | (1,435.88) | (1,348.92) | 4,170.28 | ‡‡‡‡‡ | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 420.45 | 165.99 | 907.50 | 7,051.95 | ‡‡‡‡‡ | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,540.82 | 3,439.65 | 5,515.54 | 6,694.35 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 15,268.09 | 15,735.55 | 15,500.26 | 19,197.30 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 14,545.80 | 13,659.47 | 11,788.80 | 13,987.76 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 21,009.55 | 26,081.12 | 32,316.37 | 42,939.71 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | 0.39% | 0.83% | 2.00% | 1.58% | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.28% | 1.56% | 1.65% | 0.36% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.71% | 1.44% | 3.26% | 2.49% | — | — | — |
ROE
|
Welltower Inc. (WELL), the healthcare REIT riding high on America’s aging boomers and senior housing boom, has delivered eye-popping revenue growth—from $4.28 billion in 2016 to nearly $8 billion in 2024—fueled by savvy acquisitions and rising demand. Yet, this contrarian lens reveals a fragile foundation: gross margins have cratered 30% to 39.4%, EBT remains anemic, and net income forecasts plummet to zero in 2025 amid aggressive expansion costs, hinting at a revenue cliff ahead.
The balance sheet tells a thornier tale, with persistent $15 billion debt, relentless share dilution (up 68% since 2016), and volatile capex eroding free cash flow per share. Stock prices have soared 760% from 2020 lows to $209 highs, decoupling from cratering EPS and stretched valuations (PE at 80x, PS at 9.5x), even as analyst targets offer just 2% mean upside.
Insider buys are sparse, forward oddities like an 85% revenue drop in 2026 loom, and risks from labor shortages, rates, and overleverage could unravel the narrative. Is WELL’s premium a trap or a dip-buy opportunity? Dive deeper to uncover the cracks.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.